Acadia Pharmaceuticals Inc.
The Senior Director, HEOR at Acadia Pharmaceuticals is a senior evidence and value-leadership role responsible for shaping the company’s health economics and outcomes research strategy to support access, reimbursement, and product differentiation across the product lifecycle. The position is based in San Diego, CA or Princeton, NJ and operates in a hybrid model with an average of three days per week in the office. The role partners with commercial, clinical, regulatory, and market access teams to ensure alignment of HEOR evidence generation and dissemination globally.
Headquarters
San Diego, California, United States
Company Size
501-1000 employees
Founded
1993
Acadia Pharmaceuticals is a biopharmaceutical company focused on advancing care for underserved neurological disorders and rare diseases. The company works to translate scientific promise into meaningful innovation by progressing novel therapies from research through clinical development and commercialization. Acadia’s portfolio and pipeline prioritize conditions with high unmet medical need, emphasizing patient-centered development and collaboration to accelerate access to new treatments.
Neo Ivy Capital Management Buys Shares of 62,568 ACADIA Pharmaceuticals Inc. $ACAD
4 days ago
Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.’s (ACAD) Therapeutic Domains
1 week ago
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Acadia Pharmaceuticals Inc..
Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome
1 week ago
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Associate Director, HEOR Strategy - Aesthetics
AbbVie
Director, Global HEOR - Oncology
Bristol Myers Squibb
Director, Field Health Economics & Outcomes Research (HEOR), Northeast
City of Duncan, Oklahoma
Associate Director, HEOR Japan
Revolution Medicines